Intermede Investment Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Intermede Investment Partners's DXCM Position: Q2 2026 in Review
Intermede Investment Partners reduced its DexCom (DXCM) stake by 4.6% in Q2 2026, selling an estimated $2.64M and leaving 818,840 shares worth $74.9M. The position accounts for 3.15% of the portfolio, ranked #11.
Intermede Investment Partners first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Intermede Investment Partners held 818,840 shares of DexCom worth $74.9M as of Q2 2026.
- Intermede Investment Partners sold 39,673 DexCom shares in Q2 2026, an estimated $2.64M.
- DexCom made up 3.15% of Intermede Investment Partners's portfolio in Q2 2026, its #11 holding.
- Intermede Investment Partners first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Intermede Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.